19-50403136-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_002691.4(POLD1):c.1054C>T(p.Arg352Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000346 in 1,561,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002691.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POLD1 | NM_002691.4 | c.1054C>T | p.Arg352Cys | missense_variant | Exon 9 of 27 | ENST00000440232.7 | NP_002682.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000238 AC: 4AN: 168078Hom.: 0 AF XY: 0.0000336 AC XY: 3AN XY: 89276
GnomAD4 exome AF: 0.0000369 AC: 52AN: 1409228Hom.: 0 Cov.: 32 AF XY: 0.0000417 AC XY: 29AN XY: 696250
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74350
ClinVar
Submissions by phenotype
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in an individual with polyposis in the published literature (PMID: 32792570); This variant is associated with the following publications: (PMID: 25228659, 32686686, 20951805, 36814246, 32792570) -
- -
Colorectal cancer, susceptibility to, 10 Uncertain:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 352 of the POLD1 protein (p.Arg352Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with adenomatous polyps (PMID: 32792570). ClinVar contains an entry for this variant (Variation ID: 408032). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POLD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Hereditary cancer-predisposing syndrome Uncertain:2
The p.R352C variant (also known as c.1054C>T), located in coding exon 8 of the POLD1 gene, results from a C to T substitution at nucleotide position 1054. The arginine at codon 352 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been identified in 1/2813 unrelated individuals undergoing multigene panel testing for hereditary cancer (Mur P et al. Genet Med, 2020 Dec;22:2089-2100). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
- -
not specified Uncertain:1
DNA sequence analysis of the POLD1 gene demonstrated a sequence change, c.1054C>T, in exon 9 that results in an amino acid change, p.Arg352Cys. This sequence change does not appear to have been previously described in individuals with POLD1-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.008% in the East Asian subpopulation (dbSNP rs762330164). The p.Arg352Cys change affects a highly conserved amino acid residue located in a domain of the POLD1 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg352Cys substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Arg352Cys change remains unknown at this time. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at